Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.
Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, Mills LJ, Reilly JL, Lencer R, Keedy SK, Ivleva E, Keefe RSE, Pearlson GD, Clementz BA, Tamminga CA, Keshavan MS, Gershon ES, Sweeney JA, Bishop JR.
Eum S, et al. Among authors: bishop jr.
Neuropsychopharmacology. 2021 Sep;46(10):1802-1810. doi: 10.1038/s41386-021-01057-8. Epub 2021 Jun 18.
Neuropsychopharmacology. 2021.
PMID: 34145405
Free PMC article.